Should all patients at high risk of atherothrombotic events receive dual antiplatelet therapy?
Thomas
Karen E
KE
Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA 02215, USA. dpinto@bidmc.harvard.edu
Pinto
Duane S
DS